(Q37889275)

24 August 2017

1 reference

title

The emerging role of the intestine in metabolic diseases (English)

1 reference

24 August 2017

William D Bradley

1

1 reference

PubMed ID

21671708

24 August 2017

Catherine Zwingelstein

series ordinal

2

1 reference

PubMed ID

21671708

24 August 2017

Cristina M Rondinone

series ordinal

3

1 reference

24 August 2017

1 July 2011

1 reference

Archives of Physiology and Biochemistry

24 August 2017

1 reference

24 August 2017

117

1 reference

24 August 2017

3

1 reference

24 August 2017

165-176

1 reference

Human distribution and release of a putative new gut hormone, peptide YY

24 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Gut peptides and type 2 diabetes mellitus treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Metabolic surgery and gut hormones - a review of bariatric entero-humoral modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

The gut microbiota as an environmental factor that regulates fat storage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Host-bacterial mutualism in the human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Secretin in Relation to Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Inhibition of food intake in obese subjects by peptide YY3-36

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

PKA-mediated phosphorylation of the human K(ATP) channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Cultured pancreatic ductal cells undergo cell cycle re-distribution and beta-cell-like differentiation in response to glucagon-like peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Ghrelin and energy balance: focus on current controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Effect of peptide YY3-36 on food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Biological actions and therapeutic potential of the glucagon-like peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

The biology of incretin hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

The role of gut hormones in glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

A new pathway for glucose-dependent insulinotropic polypeptide (GIP) receptor signaling: evidence for the involvement of phospholipase A2 in GIP-stimulated insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Characterization of GIP(1-30) and GIP(1-42) as stimulators of proinsulin gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Exenatide: a review from pharmacology to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

High-fat diet determines the composition of the murine gut microbiome independently of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Dipeptidyl peptidase IV-resistant [D-Ala(2)]glucose-dependent insulinotropic polypeptide (GIP) improves glucose tolerance in normal and obese diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Glucagon-Like Peptide-1 Synthetic Analogs: New Therapeutic Agents for Use in the Treatment of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Nutrient sensing and inflammation in metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Glucagon like peptide-1-directed human embryonic stem cells differentiation into insulin-producing cells via hedgehog, cAMP, and PI3K pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Therapeutic potential for GIP receptor agonists and antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Antidiabetic potential of two novel fatty acid derivatised, N-terminally modified analogues of glucose-dependent insulinotropic polypeptide (GIP): N-AcGIP(LysPAL16) and N-AcGIP(LysPAL37).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

The glucagon-like peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and dow

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Bypassing the duodenum does not improve insulin resistance associated with diet-induced obesity in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Obesity alters gut microbial ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Roux-en-Y gastric bypass promotes expression of PDX-1 and regeneration of beta-cells in Goto-Kakizaki rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

The role of the free cytosolic calcium level in beta-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide I(7-37).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Exenatide and liraglutide: different approaches to develop GLP-1 receptor agonists (incretin mimetics)--preclinical and clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

GIP receptors and signal-transduction mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Toll-like receptors and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Gastric inhibitory polypeptide: the neglected incretin revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

The effect of glyburide on beta-cell sensitivity to glucose-dependent insulinotropic polypeptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

On the treatment of Diabetus mellitus by acid extract of Duodenal Mucous Membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

The endocannabinoid system links gut microbiota to adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Microbes in gastrointestinal health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Cellular localization of gastric inhibitory polypeptide in the duodenum and jejunum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

The role of the small bowel in the regulation of circulating ghrelin levels and food intake in the obese Zucker rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Gut microbiota in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

TLR4 links innate immunity and fatty acid-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Lower mean weight after 14 days intravenous administration peptide YY3-36 (PYY3-36) in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

TGR5-mediated bile acid sensing controls glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Glucagon-like peptide 1 receptor agonist ZP10A increases insulin mRNA expression and prevents diabetic progression in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta(INS-1)-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

GIP regulates glucose transporters, hexokinases, and glucose-induced insulin secretion in RIN 1046-38 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Suppression of p38 MAPK and JNK via Akt-mediated inhibition of apoptosis signal-regulating kinase 1 constitutes a core component of the beta-cell pro-survival effects of glucose-dependent insulinotropic polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

A GIP receptor agonist exhibits beta-cell anti-apoptotic actions in rat models of diabetes resulting in improved beta-cell function and glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Gut hormones and appetite control

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Human gut microbiota in obesity and after gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2011.578651

10.3109/13813455.2011.578651

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21671708